AR112265A1 - Antagonista del receptor de angiotensina ii para la prevención o tratamiento de enfermedades sistémicas en gatos - Google Patents
Antagonista del receptor de angiotensina ii para la prevención o tratamiento de enfermedades sistémicas en gatosInfo
- Publication number
- AR112265A1 AR112265A1 ARP180101883A AR112265A1 AR 112265 A1 AR112265 A1 AR 112265A1 AR P180101883 A ARP180101883 A AR P180101883A AR 112265 A1 AR112265 A1 AR 112265A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- sartan
- angiotensin
- amount
- prophylaxis
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 8
- 239000002333 angiotensin II receptor antagonist Substances 0.000 title abstract 2
- 229940126317 angiotensin II receptor antagonist Drugs 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000009885 systemic effect Effects 0.000 title 1
- 241000282326 Felis catus Species 0.000 abstract 3
- 238000011321 prophylaxis Methods 0.000 abstract 3
- 102000008873 Angiotensin II receptor Human genes 0.000 abstract 2
- 108050000824 Angiotensin II receptor Proteins 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 2
- 239000005557 antagonist Substances 0.000 abstract 2
- 239000012669 liquid formulation Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 230000037396 body weight Effects 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 230000007423 decrease Effects 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762529587P | 2017-07-07 | 2017-07-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR112265A1 true AR112265A1 (es) | 2019-10-09 |
Family
ID=62904440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180101883 AR112265A1 (es) | 2017-07-07 | 2018-07-05 | Antagonista del receptor de angiotensina ii para la prevención o tratamiento de enfermedades sistémicas en gatos |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10905676B2 (ja) |
| EP (2) | EP3648761B1 (ja) |
| JP (2) | JP7050893B2 (ja) |
| KR (2) | KR20230161541A (ja) |
| CN (1) | CN110785168A (ja) |
| AR (1) | AR112265A1 (ja) |
| AU (1) | AU2018295387B2 (ja) |
| BR (1) | BR112020000194A2 (ja) |
| CA (1) | CA3067918A1 (ja) |
| DK (1) | DK3648761T3 (ja) |
| EA (1) | EA202090205A1 (ja) |
| FI (1) | FI3648761T3 (ja) |
| LT (1) | LT3648761T (ja) |
| NZ (1) | NZ759782A (ja) |
| TW (1) | TW201919703A (ja) |
| WO (1) | WO2019008077A1 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220054291A (ko) | 2019-07-09 | 2022-05-02 | 베링거잉겔하임베트메디카게엠베하 | 개의 만성 신장 질환 치료를 위한 텔미사르탄 |
| WO2021006942A1 (en) | 2019-07-09 | 2021-01-14 | Boehringer Ingelheim Vetmedica Gmbh | Telmisartan for the treatment of hypertension in dogs |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5671074A (en) | 1979-11-12 | 1981-06-13 | Takeda Chem Ind Ltd | 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative |
| CA1334092C (en) | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
| US5015651A (en) | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
| US4880804A (en) | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
| CA1338238C (en) | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
| IE70593B1 (en) | 1989-09-29 | 1996-12-11 | Eisai Co Ltd | Biphenylmethane derivative the use of it and pharmacological compositions containing same |
| DE122007000050I1 (de) | 1990-02-19 | 2007-11-08 | Novartis Ag | Acylverbindungen |
| NZ237476A (en) | 1990-03-20 | 1994-01-26 | Sanofi Sa | N-substituted heterocyclic compounds and pharmaceutical compositions. |
| US5196444A (en) | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
| IL99246A0 (en) | 1990-09-10 | 1992-07-15 | Abbott Lab | Angiotensin ii receptor antagonists and pharmaceutical compositions containing them |
| US6028091A (en) | 1990-12-14 | 2000-02-22 | Smithkline Beecham Plc | Medicament |
| GB9027210D0 (en) | 1990-12-14 | 1991-02-06 | Smithkline Beecham Plc | Medicaments |
| SI9210098B (sl) | 1991-02-06 | 2000-06-30 | Dr. Karl Thomae | Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo |
| US5196537A (en) | 1991-03-21 | 1993-03-23 | G. D. Searle & Co. | 5-apylheteroarylalkyl-1,3,5-trisubstituted-1,2,4-triazole compounds for treatment of circulatory disorders |
| GB9110636D0 (en) | 1991-05-16 | 1991-07-03 | Glaxo Group Ltd | Chemical compounds |
| DK0636027T3 (da) | 1992-04-13 | 2000-01-31 | Zeneca Ltd | Angiotensin-II-antogonister mod sygdomme forbundet med forringet neuronal ledningshastighed, især diabetisk neuropati |
| JP3883205B2 (ja) | 1994-03-29 | 2007-02-21 | メルク エンド カンパニー インコーポレーテッド | アンギオテンシン▲ｉｉ▼レセプタ遮断イミダゾールによるアテローム性動脈硬化症の治療 |
| US6358986B1 (en) | 1999-01-19 | 2002-03-19 | Boehringer Ingelheim Pharma Kg | Polymorphs of telmisartan |
| DE19901921C2 (de) | 1999-01-19 | 2001-01-04 | Boehringer Ingelheim Pharma | Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels |
| DE10018401A1 (de) | 2000-04-13 | 2001-10-25 | Boehringer Ingelheim Pharma | Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen |
| CA2445913A1 (en) | 2001-05-14 | 2003-10-29 | Merck & Co., Inc. | Method of treatment |
| DE10153737A1 (de) | 2001-10-31 | 2003-05-28 | Boehringer Ingelheim Pharma | Kristallines Natriumsalz des Telmisartans, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
| US8980870B2 (en) | 2002-09-24 | 2015-03-17 | Boehringer Ingelheim International Gmbh | Solid telmisartan pharmaceutical formulations |
| EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
| US20070026026A1 (en) | 2005-08-01 | 2007-02-01 | David Delmarre | Oral liquid losartan compositions |
| EP1908469A1 (en) | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
| CA2653011A1 (en) * | 2008-12-03 | 2010-06-03 | Apotex Technologies Inc | Method and apparatus for packaging and dispensing pharmaceuticals |
| DK2432452T3 (en) * | 2009-05-20 | 2016-10-10 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutically telmisartan drink solution |
| US9937154B2 (en) * | 2015-06-10 | 2018-04-10 | Hackensak University Medical Center | Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases |
| EP3509597A1 (en) | 2016-09-07 | 2019-07-17 | Saniona A/S | Tesofensine compositions |
-
2018
- 2018-07-05 NZ NZ759782A patent/NZ759782A/en unknown
- 2018-07-05 DK DK18740153.4T patent/DK3648761T3/da active
- 2018-07-05 FI FIEP18740153.4T patent/FI3648761T3/fi active
- 2018-07-05 LT LTEPPCT/EP2018/068189T patent/LT3648761T/lt unknown
- 2018-07-05 EP EP18740153.4A patent/EP3648761B1/en active Active
- 2018-07-05 BR BR112020000194-5A patent/BR112020000194A2/pt active Search and Examination
- 2018-07-05 KR KR1020237039620A patent/KR20230161541A/ko not_active Application Discontinuation
- 2018-07-05 TW TW107123267A patent/TW201919703A/zh unknown
- 2018-07-05 JP JP2020500145A patent/JP7050893B2/ja active Active
- 2018-07-05 EA EA202090205A patent/EA202090205A1/ru unknown
- 2018-07-05 AU AU2018295387A patent/AU2018295387B2/en active Active
- 2018-07-05 WO PCT/EP2018/068189 patent/WO2019008077A1/en unknown
- 2018-07-05 AR ARP180101883 patent/AR112265A1/es unknown
- 2018-07-05 EP EP23204038.6A patent/EP4299120A3/en active Pending
- 2018-07-05 CA CA3067918A patent/CA3067918A1/en active Pending
- 2018-07-05 CN CN201880033892.1A patent/CN110785168A/zh active Pending
- 2018-07-05 KR KR1020207003639A patent/KR20200026975A/ko not_active Application Discontinuation
- 2018-07-05 US US16/027,422 patent/US10905676B2/en active Active
-
2020
- 2020-12-22 US US17/131,312 patent/US20210106564A1/en active Pending
-
2022
- 2022-02-18 JP JP2022023799A patent/JP7402907B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7402907B2 (ja) | 2023-12-21 |
| EA202090205A1 (ru) | 2020-06-02 |
| US20210106564A1 (en) | 2021-04-15 |
| JP2020526516A (ja) | 2020-08-31 |
| KR20200026975A (ko) | 2020-03-11 |
| US10905676B2 (en) | 2021-02-02 |
| JP7050893B2 (ja) | 2022-04-08 |
| CA3067918A1 (en) | 2019-01-10 |
| JP2022075670A (ja) | 2022-05-18 |
| DK3648761T3 (da) | 2024-06-24 |
| TW201919703A (zh) | 2019-06-01 |
| EP3648761A1 (en) | 2020-05-13 |
| LT3648761T (lt) | 2024-06-10 |
| FI3648761T3 (fi) | 2024-05-21 |
| EP4299120A3 (en) | 2024-03-06 |
| BR112020000194A2 (pt) | 2020-07-07 |
| KR20230161541A (ko) | 2023-11-27 |
| US20190008831A1 (en) | 2019-01-10 |
| WO2019008077A1 (en) | 2019-01-10 |
| NZ759782A (en) | 2023-06-30 |
| EP3648761B1 (en) | 2024-03-13 |
| CN110785168A (zh) | 2020-02-11 |
| EP4299120A2 (en) | 2024-01-03 |
| AU2018295387B2 (en) | 2024-02-15 |
| AU2018295387A1 (en) | 2020-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2508290T3 (es) | Composición farmacéutica para la administracón de compuestos de inhibición del receptor de tirosina cinasa (RTKI) al ojo | |
| PE20210401A1 (es) | Composiciones farmaceuticas que comprenden meloxicam | |
| PH12015502691A1 (en) | Use of high dose pridopidine for treating huntington's disease | |
| RU2014109074A (ru) | ИНГИБИТОРЫ ФАННИ-ТОКА (If), ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ПРИМЕНЕНИЯ В СПОСОБЕ ЛЕЧЕНИЯ И ПРЕДУПРЕЖДЕНИЯ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ У КОШАЧЬИХ | |
| MX2019001596A (es) | Uso y dosificacion de agentes terapeuticos para endometriosis. | |
| BR112019005168A2 (pt) | composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente que sofre ou susceptível de sofrer de um distúrbio respiratório, para melhoria da estabilidade de uma composição farmacêutica e do desempenho de aerossolização de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica | |
| AR112265A1 (es) | Antagonista del receptor de angiotensina ii para la prevención o tratamiento de enfermedades sistémicas en gatos | |
| RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
| JP2016512564A5 (ja) | ||
| FI3229828T3 (fi) | Glargiini-insuliinin/liksisenatidin vakiosuhteinen formulaatio | |
| MA39443A1 (fr) | Nouvelle formulation de méloxicam | |
| CL2019003533A1 (es) | Uso de vibegron para tratar vejiga sobreactiva. | |
| CO2021007186A2 (es) | Composición farmacéutica para el tratamiento de la hipertensión arterial pulmonar | |
| AR043259A1 (es) | Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello | |
| BR112019005120A2 (pt) | composição farmacêutica, recipiente vedado, inalador de dose medida, e, métodos para tratar um paciente sofrendo ou susceptível de sofrer de um distúrbio respiratório, para melhorar a estabilidade de uma composição farmacêutica, para melhorar o desempenho de dispersão em aerossol após armazenamento de uma composição farmacêutica e para reduzir o potencial de aquecimento global de uma composição farmacêutica. | |
| CY1124236T1 (el) | Διαλυμα εγχυσης λεβοντοπα | |
| Mejía-Chew et al. | Resolution of massive tophaceous gout with three urate-lowering drugs | |
| CO2021011046A2 (es) | Composición farmacéutica que comprende macitentán para el tratamiento de la hipertensión pulmonar tromboembólica crónica | |
| RU2015119223A (ru) | Система дозированного распределения | |
| AR068531A1 (es) | Dosis fija por inyeccion unica para ocrelizumab (2h7). uso de rituximab. formulacion farmaceutica. kit. | |
| PE20130782A1 (es) | Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo | |
| JP2016538295A5 (ja) | ||
| HRP20201233T1 (hr) | Spoj izveden od pirazolina i njegova primjena u tjednom doznom režimu protiv upale i bola porijeklom od degenerativnog oboljenja zgloba kod sisavaca | |
| AR111803A1 (es) | Derivado de ciclopentan[g]quinazolin-4-ona y su empleo en el tratamiento de cáncer resistente al platino | |
| PE20040706A1 (es) | Derivado especifico de amina ciclica y sus sales farmaceuticamente aceptables involucrados en la prevencion de la insuficiencia cardiaca |